Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease

The use of antiretroviral drugs is accompanied by the emergence of HIV-2 resistances. Thus, it is important to elucidate the mechanisms of resistance to antiretroviral drugs. Here, we propose a structural analysis of 31 drug-resistant mutants of HIV-2 protease (PR2) that is an important target again...

Full description

Bibliographic Details
Main Authors: Pierre Laville, Michel Petitjean, Leslie Regad
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/3/611
_version_ 1797407617136459776
author Pierre Laville
Michel Petitjean
Leslie Regad
author_facet Pierre Laville
Michel Petitjean
Leslie Regad
author_sort Pierre Laville
collection DOAJ
description The use of antiretroviral drugs is accompanied by the emergence of HIV-2 resistances. Thus, it is important to elucidate the mechanisms of resistance to antiretroviral drugs. Here, we propose a structural analysis of 31 drug-resistant mutants of HIV-2 protease (PR2) that is an important target against HIV-2 infection. First, we modeled the structures of each mutant. We then located structural shifts putatively induced by mutations. Finally, we compared wild-type and mutant inhibitor-binding pockets and interfaces to explore the impacts of these induced structural deformations on these two regions. Our results showed that one mutation could induce large structural rearrangements in side-chain and backbone atoms of mutated residue, in its vicinity or further. Structural deformations observed in side-chain atoms are frequent and of greater magnitude, that confirms that to fight drug resistance, interactions with backbone atoms should be favored. We showed that these observed structural deformations modify the conformation, volume, and hydrophobicity of the binding pocket and the composition and size of the PR2 interface. These results suggest that resistance mutations could alter ligand binding by modifying pocket properties and PR2 stability by impacting its interface. Our results reinforce the understanding of the effects of mutations that occurred in PR2 and the different mechanisms of PR2 resistance.
first_indexed 2024-03-09T03:44:09Z
format Article
id doaj.art-196adc4d02ab4ad28892c2e872418241
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T03:44:09Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-196adc4d02ab4ad28892c2e8724182412023-12-03T14:35:52ZengMDPI AGMolecules1420-30492021-01-0126361110.3390/molecules26030611Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 ProteasePierre Laville0Michel Petitjean1Leslie Regad2Université de Paris, BFA, UMR 8251, CNRS, ERL U1133, Inserm, F-75013 Paris, FranceUniversité de Paris, BFA, UMR 8251, CNRS, ERL U1133, Inserm, F-75013 Paris, FranceUniversité de Paris, BFA, UMR 8251, CNRS, ERL U1133, Inserm, F-75013 Paris, FranceThe use of antiretroviral drugs is accompanied by the emergence of HIV-2 resistances. Thus, it is important to elucidate the mechanisms of resistance to antiretroviral drugs. Here, we propose a structural analysis of 31 drug-resistant mutants of HIV-2 protease (PR2) that is an important target against HIV-2 infection. First, we modeled the structures of each mutant. We then located structural shifts putatively induced by mutations. Finally, we compared wild-type and mutant inhibitor-binding pockets and interfaces to explore the impacts of these induced structural deformations on these two regions. Our results showed that one mutation could induce large structural rearrangements in side-chain and backbone atoms of mutated residue, in its vicinity or further. Structural deformations observed in side-chain atoms are frequent and of greater magnitude, that confirms that to fight drug resistance, interactions with backbone atoms should be favored. We showed that these observed structural deformations modify the conformation, volume, and hydrophobicity of the binding pocket and the composition and size of the PR2 interface. These results suggest that resistance mutations could alter ligand binding by modifying pocket properties and PR2 stability by impacting its interface. Our results reinforce the understanding of the effects of mutations that occurred in PR2 and the different mechanisms of PR2 resistance.https://www.mdpi.com/1420-3049/26/3/611drug-resistance mutationsHIV-2 proteasestructural characterizationinduced structural deformations
spellingShingle Pierre Laville
Michel Petitjean
Leslie Regad
Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
Molecules
drug-resistance mutations
HIV-2 protease
structural characterization
induced structural deformations
title Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
title_full Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
title_fullStr Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
title_full_unstemmed Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
title_short Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
title_sort structural impacts of drug resistance mutations appearing in hiv 2 protease
topic drug-resistance mutations
HIV-2 protease
structural characterization
induced structural deformations
url https://www.mdpi.com/1420-3049/26/3/611
work_keys_str_mv AT pierrelaville structuralimpactsofdrugresistancemutationsappearinginhiv2protease
AT michelpetitjean structuralimpactsofdrugresistancemutationsappearinginhiv2protease
AT leslieregad structuralimpactsofdrugresistancemutationsappearinginhiv2protease